The European School of Multimodality Imaging & Therapy (ESMIT) has made theranostics a special theme of its 2022 ESMIT program, as will be highlighted in several upcoming webinars.
"We believe that theranostics is here to stay. Training and education of the nuclear medicine community is of utmost importance to make theranostics a sustainable success," said Ken Herrmann, chairman of the European Association of Nuclear Medicine's Oncology & Theranostics Committee, in a statement.
Upcoming online courses include the following:
- 24-25 March: Practical Management of Thyroid Cancer: A Multidisciplinary Team Discussion
- 8 April: Next in the Pipeline of Theranostics
- 28-29 April: The Steps to Build your Successful Theranostics Team and Facility
- 6 May: Spotlight on Tumour Microenvironment: What Is Next in Imaging Phenotyping?
- 12-13 May: Quantification of MPI
For the full list of 2022 ESMIT events and details on how to register, click here.
